Bateman Horne Center Leadership are Co-Investigators on this Cutting-Edge Immunogenomic Study to Quantify ME/CFS Moving Toward a Genomic CBC for ME/CFS By Suzanne D Vernon, PhD There are two major barriers to identifying ME/CFS biomarkers: 1) variation in how patients...
In this educational seminar, Dr. Suzanne D. Vernon speaks about the Bateman Horne Center's quest to bring precision medicine to ME/CFS and Fibromyalgia. What is precision medicine and why do we need it? Precision medicine is an approach that takes into account...
Buzz - April: Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like these:...
The science of ME/CFS and FM are at a tipping point. The Bateman Horne Center (BHC) is squarely targeted on bringing these diseases to the mainstream and progress is accelerating. Our powerful combination of an active and specialized medical center of excellence with...
Uncovering Biomarkers – Is protein dysfunction a risk factor for the development of ME/CFS? The Bateman Horne Center (BHC) is determined to bring ME/CFS and FM into the mainstream by focusing on the discovery of biomarkers. Biomarkers will improve diagnosis and...
Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What's the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like these: ...
A $200,000 grant from National Institute of Allergy and Infectious Diseases has been awarded for a study seeking to identify antibody biomarkers for ME/CFS. The Bateman Horne Center will partner with Armin Alaedini, PhD on this important research. By Suzanne D Vernon...
Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What's the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like these: A new paper...
This month, a new paper out of the UK investigating mortality in individuals diagnosed with Chronic Fatigue Syndrome was featured on The Lancet home page. Among its finding, the authors noted a significant increase in the risk of suicide among those with ME/CFS. The...
Newly released paper discusses treatment strategies for ME/CFS, cites the importance of clinical intuition By Suzanne D. Vernon PhD In 2012 I organized a meeting at the Banbury Center, Cold Spring Harbor Laboratory. The objective was to bring together medical and...
Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What's the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like these: Ōuraring - Best...
Biomarkers can take the “process of elimination” out of diagnosing ME/CFS and Fibromyalgia. Biomarkers (short for biological markers) can be objectively measured and tell you something about the individual – whether there is disease present, what type of treatment...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.